Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.

MLA

Guglielmetti, Caroline, et al. “Interleukin-13 Immune Gene Therapy Prevents CNS Inflammation and Demyelination via Alternative Activation of Microglia and Macrophages.” Glia, vol. 64, no. 12, Dec. 2016, pp. 2181–200. EBSCOhost, https://doi.org/10.1002/glia.23053.

APA

Guglielmetti, C., Le Blon, D., Santermans, E., Salas, P. A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., Kara, F., Bigot, C., Mai, Z., Goossens, H., Hens, N., Hendrix, S., Verhoye, M., Planas, A. M., Berneman, Z., & van der Linden, A. (2016). Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Glia, 64(12), 2181–2200. https://doi.org/10.1002/glia.23053

Chicago

Guglielmetti, Caroline, Debbie Le Blon, Eva Santermans, Perdomo, Angelica Salas, Jasmijn Daans, Nathalie De Vocht, Disha Shah, et al. 2016. “Interleukin-13 Immune Gene Therapy Prevents CNS Inflammation and Demyelination via Alternative Activation of Microglia and Macrophages.” Glia 64 (12): 2181–2200. doi:10.1002/glia.23053.